Finerenone is a non-steroidal mineralocorticoid receptor antagonist used to reduce the risk of kidney and heart complications in patients with chronic kidney disease associated with type 2 diabetes. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Kerendia and finerenonum. Its PubChem CID is 60150535.
Finerenone
| CAS No | 1050477-31-0 |
|---|---|
| Molecular Formula | C21H22N4O3 |
| Molecular Weight | 378.40 g/mol |
| Synonyms | (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Finerenone is a non-steroidal mineralocorticoid receptor antagonist used to reduce the risk of kidney and heart complications in patients with chronic kidney disease associated with type 2 diabetes.
The listed CAS number is 1050477-31-0.
The listed molecular formula is C21H22N4O3.
The listed molecular weight is 378.40 g/mol.
(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide.
The source lists Kerendia and finerenonum.